These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8843489)

  • 1. Efficacy of mianserin on symptoms of delirium in the aged: an open trial study.
    Uchiyama M; Tanaka K; Isse K; Toru M
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):651-6. PubMed ID: 8843489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium.
    Nakamura J; Uchimura N; Yamada S; Nakazawa Y
    Int Clin Psychopharmacol; 1997 May; 12(3):147-52. PubMed ID: 9248871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delirium associated with mianserin in demented patients.
    Berilgen MS
    J Clin Psychopharmacol; 2010 Aug; 30(4):467-8. PubMed ID: 20631568
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of mianserin hydrochloride on delirium: comparison with the effects of oxypertine and haloperidol].
    Nakamura J; Uchimura N; Yamada S; Nakazawa Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):269-77. PubMed ID: 7975931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin.
    Tanum L; Malt UF
    Scand J Gastroenterol; 1996 Apr; 31(4):318-25. PubMed ID: 8726297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant whole body acupuncture in depression. A placebo-controlled study with standardized mianserin therapy].
    Röschke J; Wolf C; Kögel P; Wagner P; Bech S
    Nervenarzt; 1998 Nov; 69(11):961-7. PubMed ID: 9859117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    van Heeringen K; Zivkov M
    Br J Psychiatry; 1996 Oct; 169(4):440-3. PubMed ID: 8894194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.
    Palomäki H; Kaste M; Berg A; Lönnqvist R; Lönnqvist J; Lehtihalmes M; Hares J
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):490-4. PubMed ID: 10201422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study.
    Bahk WM; Pae CU; Tsoh J; Chae JH; Jun TY; Chul-Lee ; Kim KS
    Hum Psychopharmacol; 2002 Oct; 17(7):341-4. PubMed ID: 12415552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of childhood and adolescent depression with mianserin.
    Dugas M; Mouren MC; Halfon O; Moron P
    Acta Psychiatr Scand Suppl; 1985; 320():48-53. PubMed ID: 3863468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of trazodone and mianserin for patients with late-life chronic schizophrenia and tardive dyskinesia: an add-on, double-blind, placebo-controlled study.
    Hayashi T; Yokota N; Takahashi T; Tawara Y; Nishikawa T; Yano T; Furutani M; Fujikawa T; Horiguchi J; Yamawaki S
    Int Clin Psychopharmacol; 1997 Jul; 12(4):199-205. PubMed ID: 9347380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin].
    Brion S; Audrain S; de Bodinat C
    Presse Med; 1996 Mar; 25(9):461-8. PubMed ID: 8685201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.
    Ruiz-Doblado S; Rueda-Villar T; Zurita-Gotor P; Sanz-Cortes S
    J Psychopharmacol; 2010 Dec; 24(12):1837. PubMed ID: 21138931
    [No Abstract]   [Full Text] [Related]  

  • 17. Trazodone and Mianserin for Delirium: A Retrospective Chart Review.
    Kawano S; Ide K; Kodama K; Kikuchi Y; Sugihara H; Fujisawa D; Uchida H; Mimura M; Takeuchi H
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):560-564. PubMed ID: 36306393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mianserin efficacy in the treatment of depression].
    Ostapowicz A; Kośmicki J; Solarz J; Horodnicki JM
    Psychiatr Pol; 1996; 30(1):127-36. PubMed ID: 8722245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind controlled trial of mianserin and amitriptyline in depression.
    Mehta BM; Spear FG; Whittington JR
    Curr Med Res Opin; 1980; 7(1):14-22. PubMed ID: 7428408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
    J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.